Boehringer Ingelheim completes $76-million expansionOctober 14, 2019Boehringer Ingelheim revealed a $76-million expansion at its manufacturing plant in Athens, Ga., that will double the company’s capacity to produce vaccines for pets.
SPONSORED CONTENTA Modern Approach to Parasite PreventionWith evolving parasite threats, traditional preventatives may not be enough. Discover how innovation is changing the landscape of protection. + Learn More